Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643265 · ClinicalTrials.gov registry record · NA
Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids
A NA study of Healthy Men and Women, sponsored by Metabolic Technologies.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT01643265 is a NA study of Healthy Men and Women that has completed, run by Metabolic Technologies. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01643265, a NA study of Healthy Men and Women, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study will allow us to examine how quickly and to what extent plasma amino acids levels rise after ingesting a single dose of either whey or albumin protein. The investigators anticipate that the amino acids from albumin concentrate protein will rise as quickly and to the same extent as amino acids from whey protein. These findings will help us to understand the biological availability of these proteins and efficacy of the supplement so that consumers may be presented with nutritional options.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Whey Milk Protein
- DIETARY_SUPPLEMENT Bovine Albumin Concentrate
Study Locations (1)
Iowa
- Iowa State University - Ames
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01643265
The ClinicalTrials.gov registry entry for NCT01643265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metabolic Technologies, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Men and Women appearing as the primary indexed condition, and to 2 interventions - of which Whey Milk Protein is the first listed.
NCT01643265 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT01643265 about?
NCT01643265 is a clinical study titled "Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids". The purpose of this study will allow us to examine how quickly and to what extent plasma amino acids levels rise after ingesting a single dose of either whey or albumin protein. The investigators anticipate that the amino acids from albumin concentrate protein will rise as quickly and to the same ex...
What is the current status of trial NCT01643265?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2012-07. Estimated completion is 2012-09.
What conditions does trial NCT01643265 study?
This clinical trial studies the following conditions: Healthy Men and Women.
What interventions are being tested in trial NCT01643265?
The interventions under investigation include: Whey Milk Protein (DIETARY_SUPPLEMENT), Bovine Albumin Concentrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01643265?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01643265 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.